Switching to biosimilar and generic medicines saved the NHS over £300m in a year

NHS England saved £324m in 2017/2018 by switching from using ten “expensive” medicines to “better value and equally effective” alternatives, mainly generic and biosimilar medicines, NHS Improvement has revealed.
Source: The Pharmaceutical Journal - Category: Drugs & Pharmacology Source Type: research